| Literature DB >> 25802541 |
Muhammad Ali Hashmi1, Afsar Khan1, Muhammad Hanif1, Umar Farooq1, Shagufta Perveen2.
Abstract
Aim of the Review. To grasp the fragmented information available on the botany, traditional uses, phytochemistry, pharmacology, and toxicology of Olea europaea to explore its therapeutic potential and future research opportunities. Material and Methods. All the available information on O. europaea was collected via electronic search (using Pubmed, Scirus, Google Scholar, and Web of Science) and a library search. Results. Ethnomedical uses of O. europaea are recorded throughout the world where it has been used to treat various ailments. Phytochemical research had led to the isolation of flavonoids, secoiridoids, iridoids, flavanones, biophenols, triterpenes, benzoic acid derivatives, isochromans, and other classes of secondary metabolites from O. europaea. The plant materials and isolated components have shown a wide spectrum of in vitro and in vivo pharmacological activities like antidiabetic, anticonvulsant, antioxidant, anti-inflammatory, immunomodulatory, analgesic, antimicrobial, antiviral, antihypertensive, anticancer, antihyperglycemic, antinociceptive, gastroprotective, and wound healing activities. Conclusions. O. europaea emerged as a good source of traditional medicine for the treatment of various ailments. The outcomes of phytochemical and pharmacological studies reported in this review will further expand its existing therapeutic potential and provide a convincing support to its future clinical use in modern medicine.Entities:
Year: 2015 PMID: 25802541 PMCID: PMC4352757 DOI: 10.1155/2015/541591
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Common names of Olea europaea.
| S. no. | Region | Name |
|---|---|---|
| 1 | Spain | Aceituna, Olivera, Olivo, Oliondo, Oastre, Oliba |
| 2 | Lithuania | Alyvos |
| 3 | Portugal | Azeitona, Oliveira |
| 4 | Romania | Culoare masline, Maslin, Masliniu, Oliva |
| 5 | Albania | Dege e ullirit, Ngjyre ulliri, Ulli |
| 6 | Greece | Elia |
| 7 | Estonia | Euroopa olipuu, Olipuus |
| 8 | Sweden | Oliv, Olivgront |
| 9 | Slovakia | Oliva europska |
| 10 | Czech Republic | Oliva, Olivove drevo |
| 11 | Latvia | Olivas |
| 12 | Denmark | Oliven |
| 13 | Germany | Olivenbaum, Olbaum |
| 14 | Netherlands | Olijf |
| 15 | Israel | Eylbert. Masline, Zayit |
| 16 | India | Jaitun, Julipe, Saidun |
| 17 | Armenia | Jitabdoogh, Jiteni |
| 18 | Bulgaria | Maslina |
| 19 | Croatia | Maslinov |
| 20 | South Africa | Mohlware |
| 21 | Hungary | Olajbogyo, Olajfa, Oliva |
| 22 | England | Olewydden, Olive |
| 23 | Iceland | Olifa |
| 24 | Finland | Oliivi, Oljypuu |
| 25 | Arab World | Zaitoon |
| 26 | France | Oulivie, Olive |
| 27 | Switzerland | Uliva |
| 28 | Pakistan | Zaitun |
| 29 | Tanzania | Zeituni |
| 30 | Georgia | Zetis |
Figure 1Olea europaea: (a) tree; (b) leaves; (c) inflorescence; (d) ripe fruits; (e) stem bark.
Figure 2Chemical structures of the compounds isolated from O. europaea.
Traditional and contemporary uses of Olea europaea.
| S. no. | Part/preparation used | Ailment/use | Reference |
|---|---|---|---|
| 1 | Leaves and fruits/infusions and macerations | Hypoglycemic, hypotensive | [ |
| 2 | Decoction or infusion of fruits and leaves | Antidiabetic | [ |
| 3 | Olive oil + lemon juice | To treat gallstones | [ |
| 4 | Oil of seeds/taken orally | Laxative | [ |
| 5 | Decoctions of dried leaves and fruit/oral use | Diarrhea, respiratory, and urinary tract infections | [ |
| 6 | Olive oil/applied on scalp | To prevent hair loss | [ |
| 7 | Boiled extract of fresh leaves/taken orally | To treat asthma | [ |
| 8 | Boiled extract of dried leaves/taken orally | To treat hypertension | [ |
| 9 | Leaves extract in hot water | Diuretic | [ |
| 10 | Olive oil | Applied over fractured limbs | [ |
| 11 | Infusion of leaves/oral use | Antipyretic | [ |
| 12 | Olive fruit | Skin cleanser | [ |
| 13 | Infusion of leaves/oral use | Anti-inflammatory, tonic | [ |
| 14 | Leaf preparations | To treat gout | [ |
| 15 | Leaves of | Antibacterial | [ |
| 16 | Decoction of leaves | Antidiabetic, antihypertensive | [ |
| 17 | Fruits and leaves | Hemorrhoids, rheumatism, and vasodilator | [ |
| 18 | Infusions of leaves | Eye infections treatment | [ |
Antidiabetic activities of Olea europaea.
| S. no. | Part/type of extract/compound | Disease/assay | Animal model | Effective dose | Reference drug | Reference |
|---|---|---|---|---|---|---|
| 1 | Olive leaf biophenols (oleuropein + hydroxytyrosol) | Insulin sensitivity improvement | Middle aged overweight men | 58.8 mg | — | [ |
| 2 | Aqueous extract of leaves | Antidiabetic assay | Streptozotocin induced diabetic rats | 200 mg/Kg | Metformin | [ |
| 3 | Oleanolic acid | Diabetic neuropathy prevention | Sprague Dawley rats | 60 mg/Kg | Streptozotocin | [ |
| 4 | Ethanolic extract of leaves | Antidiabetic activity | Male adult Wistar rats | 0.5 g/Kg | Glibenclamide | [ |
| 5 | Oleuropein and hydroxytyrosol | Antidiabetic and antioxidant activities | Adult male Wistar rats | 16 mg/Kg | Trolox | [ |
| 6 | Oleuropein | Hypoglycemic and antioxidant effect | Male New Zealand rabbits | 20 mg/Kg | Alloxan | [ |
| 7 | Oleanolic acid | Antihyperglycemic activity |
| — | Oleuropein | [ |
| 8 | Oleanolic acid demethyl |
|
| — | Oleuropein | [ |
Anticancer activities of Olea europaea.
| S. no. | Part/type of extract/compound | Cell line used | Activity | Reference drug | Reference |
|---|---|---|---|---|---|
| 1 | Maslinic acid | HT29 human colon cancer cell line | Dose dependent activity | Hydroxytyrosol | [ |
| 2 | Hydroxytyrosol and hydroxytyrosyl laurate | Human monocytoid cell line | The best | H2O2 | [ |
| 3 | Oleanolic acid | Human hepatoma cell line HepG2 | Good | — | [ |
| 4 | Methanolic extract of leaves | Human leukemic cell line | High activity | 5-Bromodeoxyuridine | [ |
| 5 | Erythrodiol, uvaol, oleanolic acid, and maslinic acid | MCF-7 human breast cancer cell lines | High activity | Trolox | [ |
| 6 | Water and methanolic extracts of olive leaves | Human breast adenocarcinoma (MCF-7), human urinary bladder carcinoma (T-24), and bovine brain capillary endothelial (BBCE) | Good | FGF-2 | [ |
| 7 | Aqueous extract of leaves | MKN45 (stomach cancer), MFC7 (breast cancer), NCI-H460 (lung cancer), HCT116 (colon cancer) | Good | MTT | [ |
| 8 | Olive leaf extract | MKN45, HCT116, NCI-H460, and MCF7 | Good | — | [ |
| 9 | Erythrodiol | HT-29 human adenocarcinoma cells | Dose dependent activity | Caspase-3 | [ |
| 10 | Maslinic acid | HT29 human colon cancer cell line | Dose dependent activity | Hydroxytyrosol | [ |
| 11 | Virgin olive oil phenolics extract | HT115 human colon cancer cells | Dose dependent activity | — | [ |
| 12 | Oleuropein | HeLa human cervical carcinoma cells | Good | — | [ |
Antioxidant and antimicrobial activities of Olea europaea.
| S. no. | Part/type of extract/compound | Assay | Activity | Method/reference drug | Reference |
|---|---|---|---|---|---|
| 1 | Leaves extract | Antioxidant | High | Oxidation of soybean under microwaves | [ |
| 2 | Olive leaves infusion | Antioxidant | Good | Hydroxyl and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals | [ |
| 3 | Ethanolic extract of leaves | Antioxidant | High | DPPH radicals | [ |
| 4 | Olive fruit | Antioxidant | Good | DPPH radicals | [ |
| 5 | Volatile fractions of leaves | Antibacterial and antifungal | Moderate to high | Microwell dilution assay/DMSO | [ |
| 6 | Aqueous extract of leaves | Antimicrobial | Remarkable | Paper disc diffusion method/erythromycin | [ |
| 7 | Acetone extract of leaves | Antibacterial | Good | Paper disc diffusion method/oleuropein | [ |
| 8 | Fruit and leaves | Antioxidant | Good | DPPH radicals | [ |
| 9 | Olive pulp | Antioxidant | Excellent | Vitamin C | [ |
| 10 | Alperujo (olive waste) | Antimicrobial | Good | Syringic acid | [ |
| 11 | Volatiles of olive fruits | Antibacterial and antifungal | Moderate | Amphotericin, levofloxacin | [ |
| 12 | Aqueous extract of leaves | Antioxidant | Good | Trolox | [ |
| 13 | Leaf extract | Antioxidant | Good | DPPH radicals | [ |
| 14 | Aqueous solutions from table olives | Antibacterial and antifungal | Good | Streptomycin, oxytetracycline | [ |
| 15 | Leaves extract | Antioxidative stress | Moderate | MTT assay/oleuropein | [ |
| 16 | Maslinic acid | Antiparasitic | Dose dependent | Phenylmethanesulfonyl fluoride | [ |
| 17 | Dry extract of table olives | Antioxidant | Very good | Trolox | [ |
| 18 | Acetone extract of olive leaves + oleuropein | Antibacterial | Very good | Oleuropein | [ |
| 19 | Leaf extract | Antioxidant and antimicrobial | Excellent | Oleuropein | [ |
| 20 | Oleuropein aglycones, 3,4-DHPEA-EA, and 3,4-DHPEA-EDA | Anti-oxidative damage to erythrocytes | Good | Hydroxytyrosol | [ |
| 21 | High strength leaf extract | Antimicrobial | Excellent | — | [ |
| 22 | Dhokar cultivar olives | Antioxidant | Good | DPPH radicals | [ |
| 23 | Aqueous leaf extract | Antioxidant and antimicrobial | Good | DPPH radicals/streptomycin | [ |
| 24 | Leaf extract | Antioxidant and antimicrobial | Dose dependent | Ascorbic acid | [ |
| 25 | Phenolics released by hydrothermal treatment of olive tree pruning | Antioxidant | Good | Trolox | [ |
| 26 | Leaf extract | Antioxidant | Good | Trolox | [ |
| 27 | Aqueous extract of leaves | Antifungal | The best | Oleuropein | [ |
| 28 | Aqueous extract of leaves | Antimicrobial | Good | — | [ |
| 29 | Dialdehydic form of decarboxymethyl elenolic acid | Antimicrobial | More potent than oleuropein | Hydroxytyrosol | [ |
| 30 | Leaves sprayed with copper formulations | Antioxidant | Low activity due to decrease in phenolic content |
| [ |
| 31 | Aqueous ethanolic extract | Antioxidant activity | Good |
| [ |
| 32 | Aliphatic aldehydes from olive fruit | Antifungal and antielastase | Active except | Miconazole | [ |
| 33 | Table olives from Portugal | Antioxidant and antimicrobial | Active except |
| [ |
| 34 | Extracts of leaves, fruits, and seeds | Antioxidant | High | Trolox | [ |
| 35 | Oleuropein, hydroxytyrosol, and tyrosol | Antioxidant | High | Vitamin E, BHT | [ |
| 36 | Long chain | Antimicrobial | Broad spectrum activity | — | [ |
| 37 | Phenolics from olive oil mill waste water | Antioxidant | Good | 2,3-Tert-butyl-4-hydroxyanisole, L-ascorbic acid | [ |
| 38 | Maslinic acid | Antioxidant | Good | Silymarin | [ |
| 39 | EVOO | Antioxidant | Good | Methyl linoleate | [ |
| 40 | Phenolics | Antioxidant | Good | Ascorbic acid | [ |
Antihypertensive activities of Olea europaea.
| S. no. | Part/type of extract/compound | Assay | Activity | Reference |
|---|---|---|---|---|
| 1 | Uvaol, ursolic acid, and oleanolic acid | Cardiotonic | Good for uvaol and oleanolic acid | [ |
| 2 | Leaf extract | Antihypertensive | Very good | [ |
| 3 | Leaf extract |
| Dose dependent | [ |
| 4 | Leaves infusion |
| Active on prolonged use | [ |
| 5 | Oleanolic and ursolic acid |
| Active on 60 mg/Kg dose | [ |
| 6 | Leaf extract (EFLA 943) |
| Active on 100 mg/Kg dose | [ |
| 7 | Leaf extract (EFLA 943) | Studies in borderline hypertensive monozygotic twins | Good activity | [ |
Anti-inflammatory and antinociceptive activities of Olea europaea.
| S. no. | Part/type of extract/compound | Disease/assay | Animal model | Effective dose | Reference drug | Reference |
|---|---|---|---|---|---|---|
| 1 | Oleanolic acid | Antinociceptive | Female CD-1 mice (Barcelona, Spain) | — | Ibuprofen, pregabalin, baclofen | [ |
| 2 | Olive oil | Antinociceptive and anti-inflammatory | Male Balb/C mice | 10 mg/Kg | Dexamethasone | [ |
| 3 |
| Anti-inflammatory and antinociceptive | Male Swiss albino mice | 400 mg/Kg | Indomethacin, acetylsalicylic acid | [ |
| 4 | Olive oil | Analgesic and anti-inflammatory | Male Wistar rats | 100–300 mg/Kg | Acetyl salicylate of lysine | [ |
| 5 |
| Anti-inflammatory and antinociceptive | Male Swiss albino mice | 400 mg/Kg | Indomethacin, acetylsalicylic acid | [ |
| 6 | Ethanolic extract of dry leaves | Antinociceptive, antihyperalgesic | Male Wistar rats | 200 mg/Kg | Morphine | [ |
| 7 | EVOO, Oleocanthal | Ibuprofen like activity |
| — | Ibuprofen | [ |